{"organizations": [], "uuid": "2f173634bb177d3336e11f815f951460af3227a3", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/idUSFWN1RG0JK", "country": "US", "domain_rank": 408, "title": "REFILE-Palatin Technologies Presents Preclinical Data On Investigational Treatment For IBD", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-04-03T19:37:00.000+03:00", "replies_count": 0, "uuid": "2f173634bb177d3336e11f815f951460af3227a3"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/idUSFWN1RG0JK", "ord_in_thread": 0, "title": "REFILE-Palatin Technologies Presents Preclinical Data On Investigational Treatment For IBD", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "palatin technologies inc", "sentiment": "negative"}, {"name": "ibd", "sentiment": "negative"}, {"name": "palatin", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "(Corrects headline to say “IBD”, not “IBS”)\nApril 3 (Reuters) - Palatin Technologies Inc:\n* PALATIN TECHNOLOGIES PRESENTS PRECLINICAL ORAL FORMULATION DATA ON PL-8177, AN INVESTIGATIONAL MELANOCORTIN RECEPTOR 1 AGONIST FOR INFLAMMATORY BOWEL DISEASES\n* PALATIN TECHNOLOGIES INC - SUBJECT DOSING IS ONGOING WITH TOP LINE DATA CURRENTLY EXPECTED IN Q3 OF 2018 FOR PL-8177 Source text for Eikon:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-03T19:37:00.000+03:00", "crawled": "2018-04-03T15:15:36.015+03:00", "highlightTitle": ""}